Moderna(MRNA)
Focus: Moderna is a Cambridge-based mRNA therapeutic company with ~5,900 employees that pioneered RNA vaccine technology and commercialized COVID-19 vaccines at scale. The company operates as a public biotech leader in vaccine development with emerging oncology and rare disease programs.
Profile data last refreshed 8h ago · AI intelligence enriched 1mo ago
Funding Stage
PUBLIC
Employees
5,900
Open Jobs
189+70 this month
Hot — 152 jobs added in 30d
Net +70 (152 new, 82 removed). Aggressive expansion phase.
Should You Work at Moderna?
AI assessmentStrong for mRNA specialists and platform technologists, but evaluate financial stability carefully given FY2025 losses and COVID revenue cliff.
Why Work Here
- Work at the epicenter of mRNA platform technology with proven commercial validation ($19.3B FY2024 revenue) and deep cash reserves ($3.2B) supporting long-term R&D.
- Access expanding pipeline across vaccines, oncology, and rare diseases with 30+ active programs spanning Phase 1 through Phase 4, offering diverse technical career paths.
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$6.8B
Key Products
Growth
Early commercial success in RSV market with multiple Phase 2/3 trials active, representing core vaccine diversification strategy.
Help build intelligence for Moderna
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.